Insiders sell three keywords involved in very different parts of the artificial intelligence (AI) value chain. This includes one of the world's largest AI model developers, the newest AI chip developer to go public, and the largest neocloud on the market. However, insider trading can often send dirty and ambiguous signals. So, are these latest moves just noise, or are they telling investors something important?
Alibaba Sees Spike in Sales, But Only 1 Story
Alibaba Group Today
- 52 week interval
- $91.99
▼
$192.67
- Dividend Yield
- 1.05%
- The P/E ratio
- 16.04
- Target Value
- $187.38
Alibaba Group NYSE: BABA is well known for its largest e-commerce platform in China. However, outside of the United States, Alibaba is also one of the world's largest investors in AI. The company has developed its family of Qwen models. Although not considered a “borderline model,” Qwen has shown strong abilities from an intellectual standpoint.
Notably, Alibaba recently saw a spike in inbound sales. Sales came in at about $71 million in Q2, all through the end of June. Notably, none of these sales have been subject to a predetermined 10b5-1 plan, indicating that they were discretionary in nature. However, for most of these sales, that is not true. In addition to company president Michael Evans' $68.3 million sale, insiders sold shares to pay taxes on restricted stock units. Because of that, he had no choice or concern. However, Evans' sales were very large and optional. Notably, on June 29, 2026, Evans sold almost all of his shares in two transactions, reducing his stake from 720,000 to just 28,000.
All in all, this huge sale is about moderation. However, only one person makes such a sale. Going forward, investors may want to monitor whether other insiders are divesting their holdings to the same extent, which could indicate greater panic among insiders.
Insider Sales Eclipse $20 Million After Cerberus IPO
Cerebras Systems Today
Cerebral Systems
- 52 week interval
- $160.81
▼
$386.34
- Target Value
- $299.30
Cerebral Systems NASDAQ: CBRS went public in May 2026, coming to market with a very different product in the AI semiconductor space. The industry recognizes the company for its “wafer-level” chips. Multiple semiconductors are often cut from a single wafer during chip manufacturing. In the case of Cerebras, each chip is the equivalent of a full wafer. The company says this increases efficiency and has signed deals with OpenAI and Amazon.com NASDAQ: AMZN providing chips.
However, shares have fallen since going public, down more than 30%. Notably, Cerebras uses a dramatic IPO lock-in expiration, which allows insiders to sell shares before the typical 90 to 180-day waiting period. Subsequently, insiders have sold approximately $21 million worth of stock in the past few weeks. None of these sales came under 10b5-1 plans. All in all, these insiders are clearly looking for liquidity as stocks have fallen sharply, which is a somewhat concerning sign of foresight.
It is also important to note that approximately 28 million shares held by directors, officers and non-employee investors are eligible for sale after Cerebras' latest earnings report. Actual insider sales reported so far, however, represent a fraction of that amount, indicating that insiders may be showing restraint despite having a much larger selling window.
CoreWeave Sales Reach All-Time Highs in Q2
CoreWeave Today
- 52 week interval
- $63.80
▼
$160.42
- Target Value
- $135.00
CoreWeave NASDAQ: CRWV is a well-known AI neocloud. CoreWeave has experienced the highest level of insider sales since going public in March 2025. In total, MarketBeat has tracked nearly $8.5 billion in insider sales over the past 12 months. Notably, CoreWeave saw its internal sales drop significantly to $396 million in Q1 2026. This compares to sales of more than $2 billion in each of the previous two quarters, indicating that CoreWeave's sales may be declining. However, Q2 2026 ended up being CoreWeave's biggest quarter ever for domestic sales, with the figure coming in at $3.27 billion.
Most of CoreWeave's internal sales come with 10b5-1 systems. While this often affects internal sales, the company's raw sales are so large that it doesn't change the picture much. Insiders have shown a pattern of overselling this stock. That is a real warning sign for investors. Additionally, as shares rose 28% in Q2 2026, insider sales increased, putting pressure on the rally as insiders sold on it. Overall, CoreWeave's internal sales are not only bearish indicators but also creating a structural jump in valuation.
CoreWeave Sales Raise Red Flags; Monitor Alibaba and Cerebras
Taken together, CoreWeave's internal sales are the only ones that should cause real concern for investors at this point. The scale and persistence of the sale creates a structural overhang that is hard to ignore, even if most of the work is done under 10b5-1 plans.
Alibaba and Cerebras are still worth watching, but their recent internal work seems more distant or relatively restrained. For investors, the real signal is not that AI insiders are selling. Whether those sales are normal liquidity events, post-IPO capitalization or evidence that insiders are seeing upside after a strong run.
Before you consider Alibaba Group, you'll want to hear this.
MarketBeat tracks Wall Street's top and most effective research analysts and the stocks they recommend to their clients every day. MarketBeat identified five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Alibaba Group wasn't on the list.
Although Alibaba Group currently has an average buy rating among analysts, top analysts believe these five stocks are the best.
View Five Stocks Here
Discover the 10 Best Stocks to Go for 2026 and secure a reliable income in uncertain markets. Download the report now to identify high dividend payers and avoid common dividend pitfalls.
Get This Free Report
